Viewing Study NCT07042594


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-01-06 @ 1:32 PM
Study NCT ID: NCT07042594
Status: RECRUITING
Last Update Posted: 2025-12-11
First Post: 2025-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD1119 in Healthy Participants
Sponsor: Suzhou Ribo Life Science Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module